# Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient

> **NCT02333474** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fuda Cancer Hospital, Guangzhou** · enrollment: 20 (estimated)

## Conditions studied

- Lung Neoplasms

## Interventions

- **BIOLOGICAL:** MV mix vaccine
- **OTHER:** standard treatment

## Key facts

- **NCT ID:** NCT02333474
- **Lead sponsor:** Fuda Cancer Hospital, Guangzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02333474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02333474, "Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02333474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*